Archive - March 2019
Karyopharm Announces FDA Extension of Review Period for Selinexor New Drug Application
Evoke Pharma Submits Response to FDA Review Letter for Gimoti NDA
Pfizer hedges bets on gene therapy deal
Sage’s postpartum depression treatment Zulresso gains US approval
Roche bags small cell lung cancer nod for Tecentriq
Merck, Pfizer pull the plug on ovarian cancer trial
US approves first treatment for post-partum depression
GSK’s endometrial cancer drug to be filed later this year